Financial News
Latest News about AMGN
Recent news which mentions AMGN
From MarketWatch
From Benzinga
The Daily Biotech Pulse: Liquidia Jumps On New CEO Appointment, Spectrum, Aravive Secure New Funding, Allena To Explore Strategic Alternatives
January 04, 2022
From Benzinga
Meet the 2022 Dogs of the Dow
January 04, 2022
From Motley Fool
From Motley Fool
Could This FDA Approval Create a Blockbuster Drug for AbbVie?
January 02, 2022
From Motley Fool
These 3 Stocks Just Hiked Their Dividends: Should You Buy Them?
January 01, 2022
From Motley Fool
Could AstraZeneca Help You Retire a Millionaire?
January 01, 2022
From Motley Fool
Wall Street analysts’ favorite stocks for 2022 include Alaska Air, Caesars and Lithia Motors
December 31, 2021
From MarketWatch
These 8 Dow Jones Stocks Are Negative For 2021
December 30, 2021
From Benzinga
These are the best-performing S&P 500 and Nasdaq-100 stocks of 2021
December 30, 2021
From MarketWatch
From InvestorPlace
Synthetic Biology Platform Senti Bio Rides On Omid Farokhzad's SPAC For NASDAQ Debut
December 20, 2021
From Benzinga
From Benzinga
The Week Ahead In Biotech (Dec. 19-25): Amgen And Aquestive Regulatory Decisions Key Events Of Holiday-Shortened Week
December 19, 2021
From Benzinga
These 2 Dividend ETFs Are a Retiree's Best Friend
December 17, 2021
From Motley Fool
Is It Time to Buy the 8 Worst-Performing Dividend Stocks of 2021?
December 15, 2021
From Motley Fool
Piclidenoson Takes On Otezla, a $13 Billion Psoriasis Drug
December 14, 2021
From Benzinga
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
December 14, 2021
From Motley Fool
2 Top Dividend Stocks That Just Hiked Their Payouts by 10% or More
December 13, 2021
From Motley Fool
Is It Time to Buy the Dow's 3 Worst Performing Stocks This Year?
December 10, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
December 09, 2021
From Benzinga
Early Clinical Data Suggest This New Lotion Could Offer Best-In-Class Eczema Treatment and Infection Prevention, According to Hoth Therapeutics
December 07, 2021
From Benzinga
Can-Fite Expects Data Readout From Late-Stage Psoriasis Study With Piclidenoson In Q1 2022
December 07, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021
December 06, 2021
From Benzinga
3 Must-Own Dividend Stocks in This Chaotic Market
December 06, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.